Masimo has received approval to market its rainbow DCI-mini system in Europe and Japan, and is preparing for a limited commercial release of the product. The device, which monitors hemoglobin levels in small children and infants in a noninvasive manner, is the first of its type approved for use on children weighing less than 22 pounds.
Masimo gains OK for infant hemoglobin monitor in Europe, Japan
SmartBrief Job Listings for Health Care
|Senior Director, Biostatistics||
|Associate - Food and Drug||
Keller and Heckman LLP
|Senior Paralegal - Research & Development, and Medical||